Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma, Head And Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04141449
What this trial is testing

A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation

Who this might be right for
NeoplasmsHivCervical Cancer+5 more
Brigham and Women's Hospital 874
Testing effectiveness (Phase 2)UnknownNCT06055166
What this trial is testing

A Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid Tumors

Who this might be right for
PARP Inhibitor for Esophageal Squamous Cell Carcinoma
Chongqing University Cancer Hospital 120
Not applicableNot Yet RecruitingNCT07745803
What this trial is testing

Discovery and Validation of Biomarkers for Periodontitis, Dental Caries and Oral Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Periodontal DiseaseDental Caries
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 4,000
Not applicableStudy completedNCT01816841
What this trial is testing

Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care

Who this might be right for
Lip and Oral Cavity Squamous Cell CarcinomaOral Cavity Verrucous CarcinomaStage 0 Lip and Oral Cavity Cancer+1 more
Ohio State University Comprehensive Cancer Center 68
Not applicableLooking for participantsNCT07546383
What this trial is testing

A Study Investigating the Efficacy and Safety of the Combination of Iparomlimab and Tuvonralimab With or Without Chemotherapy in Second-line and Subsequent Treatments for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
The Second Affiliated Hospital of Hainan Medical University 32
Testing effectiveness (Phase 2)Ended earlyNCT01415986
What this trial is testing

Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Arkansas 1
Testing effectiveness (Phase 2)Looking for participantsNCT06857279
What this trial is testing

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Carcinoma of Head and/or Neck
Shanghai Henlius Biotech 167
Testing effectiveness (Phase 2)Looking for participantsNCT07457346
What this trial is testing

A Study Testing Emactinib Sulfate With Chemotherapy and Immunotherapy Before Surgery for Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer Squamous Cell Carcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 76
Testing effectiveness (Phase 2)Active Not RecruitingNCT06009861
What this trial is testing

Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)

Who this might be right for
Oral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
Peking University Hospital of Stomatology 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT05108870
What this trial is testing

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Who this might be right for
Human Papilloma VirusHPVHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more
University of Chicago 35
Testing effectiveness (Phase 2)Ended earlyNCT04242173
What this trial is testing

Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma of the Head and Neck
H. Lee Moffitt Cancer Center and Research Institute 3
Early research (Phase 1)Study completedNCT03666273
What this trial is testing

Phase 1 Study of BAY1905254 - An Early Clinical Research Study to Evaluate a New Drug Called Bapotulimab (BAY1905254) in the Expansion Cohort in Combination With Pembrolizumab in Head and Neck Cancer That Has Returned or is Discovered to be Metastatic and is Expressing PDL1.

Who this might be right for
Advanced Solid TumorHead and Neck Squamous Cell Carcinoma
Bayer 60
Testing effectiveness (Phase 2)UnknownNCT03585673
What this trial is testing

Docetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal Carcinoma

Who this might be right for
Esophagus Squamous Cell Carcinoma (SCC)Metastatic Cancer
Sung Yong Oh 38
Not applicableLooking for participantsNCT07088354
What this trial is testing

Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant ImmunochemotherapyPathological Complete Response+1 more
Tongji Hospital 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT05659251
What this trial is testing

Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 48
Large-scale testing (Phase 3)Study completedNCT00002631
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Radiation Therapy Oncology Group 298
Early research (Phase 1)Enrolling By InvitationNCT07218003
What this trial is testing

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Who this might be right for
Non Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more
Rondo Therapeutics 149
Testing effectiveness (Phase 2)Ended earlyNCT04844073
What this trial is testing

TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

Who this might be right for
Squamous Cell Cancer of Head and Neck (SCCHN)Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer
Takeda 95
Not applicableStudy completedNCT00875953
What this trial is testing

Use of the Harmonic Scalpel in Neck Dissection

Who this might be right for
Neck Dissection
University of Calgary 34
Testing effectiveness (Phase 2)Study completedNCT02684253
What this trial is testing

Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Memorial Sloan Kettering Cancer Center 65
Next Page